Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kymera Therapeutics Inc shares valued at $651,766 were sold by Esposito Pamela on Sep 17 ’24. At $48.28 per share, Esposito Pamela sold 13,500 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, PAMELA ESPOSITO purchased 13,500 shares, netting a total of over 654,480 in proceeds.
Before that, Albers Jeffrey W. had sold 5,000 shares from its account. In a trade valued at $245,508, the Director traded Kymera Therapeutics Inc shares for $49.10 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $0.0.
Analysts at Wolfe Research upgraded the stock from ‘”a Peer perform”‘ to ‘”an Outperform”‘ outlook in a report released in late August. As of April 22, 2024, Oppenheimer has initiated its “an Outperform” rating for KYMR. Earlier on February 15, 2024, Wolfe Research initiated its rating. Their recommendation was “a Peer perform” for KYMR stock.
Analyzing KYMR Stock Performance
During the last five days, there has been a drop of approximately -5.25%. Over the course of the year, Kymera Therapeutics Inc shares have jumped approximately 81.34%. Shares of the company reached a 52-week high of $53.27 on 09/26/24 and a 52-week low of $22.35 on 01/04/24. A 50-day SMA is recorded $47.01, while a 200-day SMA reached $39.75. Nevertheless, trading volume fell to 0.75 million shares from 0.29 million shares the previous day.
Support And Resistance Levels for Kymera Therapeutics Inc (KYMR)
According to the 24-hour chart, there is a support level at 43.53, which, if violated, would cause prices to drop to 40.90. In the upper region, resistance lies at 47.89. The next price resistance is at 49.62. RSI (Relative Strength Index) is 47.32 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.01, which suggests the price will decrease in the coming days. Percent R is at 53.72%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
